Artificial Intelligence-Assisted Echocardiography for Early Detection of Subclinical Cardiomyopathy

Background: Subclinical cardiomyopathy represents a latent stage of myocardial dysfunction without overt symptoms, yet it significantly increases the risk of heart failure, arrhythmias, and sudden cardiac death. Early detection remains challenging using conventional imaging, which often lacks sensitivity for subtle myocardial changes. Recent advances in artificial intelligence (AI), particularly deep learning and computer vision, offer powerful tools for enhancing image interpretation and pattern recognition in echocardiography. AI-assisted platforms can extract high-dimensional features from standard transthoracic ultrasound data, enabling the identification of early structural and functional abnormalities imperceptible to human observers. Methods and Results: In this prospective study, a convolutional neural network (CNN) model was trained on over 50,000 annotated echocardiographic studies to detect early markers of cardiomyopathy, including impaired myocardial strain, regional wall motion abnormalities, and altered left atrial volumes. The model was validated on independent datasets comprising asymptomatic individuals with high-risk profiles (e.g., diabetes, chemotherapy exposure, genetic predisposition). AI-derived metrics outperformed traditional measures such as ejection fraction and fractional shortening in predicting progression to clinical heart failure. Integration with clinical variables in a hybrid prediction model improved sensitivity and specificity for subclinical cardiomyopathy to over 90%. Automated decision support tools were successfully deployed in outpatient echo labs, reducing interpretation time and enhancing diagnostic consistency. Conclusion: AI-assisted echocardiography enables accurate, reproducible, and scalable detection of subclinical cardiomyopathy before irreversible damage occurs. By uncovering subtle structural and functional deviations, this approach supports earlier intervention, risk stratification, and personalized treatment planning. These findings position AI as a transformative force in cardiovascular imaging and preventive cardiology.